Designing a clinical trial is a challenging multidisciplinary endeavor. Most people don’t think twice about asking colleagues in statistics, pharmacology and clinical medicine to ensure a study is robust. But as a field, is there a missed opportunity to engage with those who have the most to offer? What about those patients who could potentially participate in a trial? In this webinar, the featured speakers explore how participant input can be valuable to clinical trial optimization and design.
Increasingly it is heard that regulators, health technology assessment (HTA) bodies and journal publishers are calling for increased patient involvement before, during and after a trial is completed. But how does this work in practice? In this webinar, get perspectives from two experienced practitioners in the field of digital health and decentralized trials across a range of therapeutic areas. Attendees will learn about the latest regulatory thinking in the space and gain tips for putting patient involvement into practice. Attendees will also have the opportunity to ask questions.
Join this webinar to learn how to make better use of participant insights before, during and after a study to generate better evidence and ensure a more successful trial completion.
Paul Wicks, PhD, Independent Consultant
Paul Wicks, PhD, is an independent consultant who helps life sciences companies generate evidence, revenue, and awareness. Clients include pharma (AstraZeneca, COMPASS Pathways), applied artificial intelligence (AI) (Ada Health, Kheiron Medical), digital therapeutics (Constant Therapy Health, Happify Health, Woebot Health, Zemedy), investor due diligence resources (Endava), data-driven communities (HealthUnlocked, Sano Genetics), and research institutions (Wellcome Trust, University of Cambridge). Prior to consulting, for 13 years he led innovation at PatientsLikeMe, an online community for over 750,000 people living with medical conditions. Paul has over 170 peer-reviewed publications including an observational trial of lithium in amyotrophic lateral sclerosis (ALS), numerous patient-reported outcome (PRO) measures, a dose-response curve for the benefits of friendship, and applied AI in medical triage and mental health. He sits on the editorial boards of The BMJ, BMC Medicine, Journal of Medical Internet Research (JMIR), Digital Biomarkers and The Patient. His PhD at the Institute of Psychiatry (King’s College London) explored cognition and neuroimaging in ALS, with a postdoc in psychological consequences of Parkinson’s disease. His work has been profiled by the BBC, NPR, CNN, BBC Radio 4, The Wall Street Journal, and The New York Times. In 2011, he was awarded MIT Technology Review’s TR35 “Humanitarian of the Year” award, recognized as a TED Fellow in 2012, and joined the inaugural FLIER Program at the Academy of Medical Sciences in 2019.Message Presenter
Noah Goodson, PhD, Decentralized Study Design Lead, THREAD Research
Prior to joining THREAD, Noah helped early-stage biotech and medical device companies design and execute hybrid and fully decentralized research. He is well versed in the complex needs of these organizations and has spent significant time in guiding business development and scientific communication strategies with investors. As part of THREAD Consulting, Noah applies practical experience in running trials with a decentralized approach to build more efficient and inclusive studies.Message Presenter
Who Should Attend?
- Clinical Research
- Clinical Project Managers
- Data Management
- Decentralized/Remote/Virtual Trials
- Digital Innovation/Strategy
- Medical Director
- Patient Experience
- Patient Engagement
- Patient Recruitment
- Trial Design
- Therapeutic Head/Lead
What You Will Learn
In this webinar, participants will learn:
- Why the trials ecosystem is crying out for patient involvement, and how in some jurisdictions, it might soon become law
- How early evidence suggests that significant return on investment is achievable in terms of recruitment, retention and data quality
- Why patient involvement is something to plan for before a trial gets going, not after it’s in rescue mode
- Why simple approaches can include lit reviews, surveys, focus groups, but higher order co-creation yields better and more sustained improvements
THREAD is a leading provider of a proprietary, decentralized research platform and suite of supporting services used by biopharma, CROs and life science organizations to remotely capture data from participants and sites during, in-between and in lieu of in-clinic visits. THREAD’s platform and supporting services are helping customers to shorten study launch timelines, reduce study budgets with Virtual Visits, and bring studies from the clinic to patients’ homes. THREAD provides key platform features such as eConsent, eCOA/ePRO, sensors, reminders, and telehealth Virtual Visits to support remote data capture, hybrid virtual studies, and fully decentralized studies in key therapeutic areas. In 2019, THREAD was acquired by strategic health care investors Water Street Healthcare Partners and JLL Partners. Visit us at https://www.threadresearch.com/